These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 24967586)

  • 1. Combining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancer.
    Putila J; Guo NL
    PLoS One; 2014; 9(6):e100994. PubMed ID: 24967586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining clinical, pathological, and demographic factors refines prognosis of lung cancer: a population-based study.
    Putila J; Remick SC; Guo NL
    PLoS One; 2011 Feb; 6(2):e17493. PubMed ID: 21364765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    Yi YS; Ban WH; Sohng KY
    BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
    Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
    Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Real-world treatment patterns and costs in a US Medicare population with metastatic squamous non-small cell lung cancer.
    Davis KL; Goyal RK; Able SL; Brown J; Li L; Kaye JA
    Lung Cancer; 2015 Feb; 87(2):176-85. PubMed ID: 25532680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characteristics of elderly patients with COPD and newly diagnosed lung cancer, and factors associated with treatment decision.
    Qin J; Li G; Zhou J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1515-20. PubMed ID: 27445471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival impact of treatment for chronic obstructive pulmonary disease in patients with advanced non-small-cell lung cancer.
    Ajimizu H; Ozasa H; Sato S; Funazo T; Sakamori Y; Nomizo T; Kuninaga K; Ogimoto T; Hosoya K; Yamazoe M; Tsuji T; Yoshida H; Itotani R; Ueno K; Kim YH; Muro S; Hirai T
    Sci Rep; 2021 Dec; 11(1):23677. PubMed ID: 34880386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the heterogeneity of stage III non-small-cell lung cancer through incorporation of grade and histology.
    Abdel-Rahman O
    Future Oncol; 2017 Dec; 13(30):2811-2821. PubMed ID: 29188724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy.
    Omote N; Hashimoto N; Morise M; Sakamoto K; Miyazaki S; Ando A; Nakahara Y; Hasegawa Y
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3541-3547. PubMed ID: 29270008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.
    Dong W; Zhu Y; Du Y; Wang L; Feng X; Ma S
    Clin Respir J; 2020 Apr; 14(4):345-352. PubMed ID: 31876095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic obstructive lung diseases and risk of non-small cell lung cancer in women.
    Schwartz AG; Cote ML; Wenzlaff AS; Van Dyke A; Chen W; Ruckdeschel JC; Gadgeel S; Soubani AO
    J Thorac Oncol; 2009 Mar; 4(3):291-9. PubMed ID: 19190518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress in the Treatment and Outcomes for Early-Stage Non-Small Cell Lung Cancer.
    Shin JY; Yoon JK; Marwaha G
    Lung; 2018 Jun; 196(3):351-358. PubMed ID: 29550987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PIK3CA mutation as a distinctive genetic feature of non-small cell lung cancer with chronic obstructive pulmonary disease: A comprehensive mutational analysis from a multi-institutional cohort.
    Sawa K; Koh Y; Kawaguchi T; Kambayashi S; Asai K; Mitsuoka S; Kimura T; Yoshimura N; Yoshimoto N; Kubo A; Saka H; Matsumura A; Wanibuchi H; Yamamoto N; Nishiyama N; Hirata K
    Lung Cancer; 2017 Oct; 112():96-101. PubMed ID: 29191607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of medical comorbidities on the presentation and outcomes of stage I-III non-small-cell lung cancer.
    Ahn DH; Mehta N; Yorio JT; Xie Y; Yan J; Gerber DE
    Clin Lung Cancer; 2013 Nov; 14(6):644-50. PubMed ID: 23886797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
    Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
    Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 19. COPD and lung cancer among women: an equal opportunity risk?
    Mannino DM
    J Thorac Oncol; 2009 Mar; 4(3):275-6. PubMed ID: 19247079
    [No Abstract]   [Full Text] [Related]  

  • 20. Geographic variation in the use of adjuvant therapy among elderly patients with resected non-small cell lung cancer.
    Schroeder MC; Tien YY; Wright K; Halfdanarson TR; Abu-Hejleh T; Brooks JM
    Lung Cancer; 2016 May; 95():28-34. PubMed ID: 27040848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.